Company Information

  

Address: PO BOX 13628
68 TW ALEXANDER DRIVE 
City: RESEARCH TRIANGLE PARK 
State: NC 
Zip Code: 27709 
Telephone: (919) 636-4530 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Fennec Pharmaceuticals Inc. ("Fennec," the "Company," "we," "us," or "our") is a biopharmaceutical company focused on the development of PEDMARKTM (a unique formulation of Sodium Thiosulfate ("STS")) for the prevention of platinum-induced ototoxicity in pediatric cancer patients. We incorporated under the Canada Business Corporations Act ("CBCA") in September 1996. Effective on August 25, 2011, the Company continued from the Canada Business Corporations Act to the Business Corporations Act (British Columbia) (the "Continuance"). The Continuance was approved by the shareholders of Fennec at the Company's June 2011 Annual and Special Meeting and by resolution of the Board of Directors on August 10, 2011. We have three wholly-owned subsidiaries: Oxiquant, Inc. and Fennec Pharmaceuticals, Inc., both Delaware corporations, and Cadherin Biomedical Inc., a Canadian company. With the exception of Fennec Pharmaceuticals, Inc., all subsidiaries are inactive.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-0.50NAN/E
12/2017-0.47NAN/E
09/20170.23NA48.22
06/2017-0.29NAN/E
03/2017-0.24NAN/E
12/2016-0.22NAN/E
09/2016-0.18NAN/E
06/2016-0.16NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.05Total Liab/Total Assets0.06
Net Inc/Total Assets-0.25Total Liab/Inv Cap0.06
Net Inc/Inv Cap-0.26Total Liab/Comm Equity0.01
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/Equity0.01
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/Equity0.01
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio17.28
Inventory TurnoverNACurrent Ratio17.28
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 0.00 0.00 0.00 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.10 1.63 1.69 1.15
Operating Income -1.79 -2.52 -2.19 -1.48
Interest Exp NA NA NA NA
Pretax Income -1.57 -2.29 -2.35 -1.60
Other Income 0.22 0.18 -0.17 -0.12
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -1.57 -2.29 -2.35 -1.60

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 26.72 28.26 9.69 10.23
Receivables - Total NA NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 26.84 28.40 9.89 10.26
Net Property, Plant & Equipment NA NA NA NA
Total Assets 26.84 28.40 9.89 10.26
Liabilities        
Accounts Payable 1.17 1.48 0.66 0.39
Debt in Current Liabilities 0.00 0.17 0.37 0.19
Total Current Liabilities 1.17 1.64 1.03 0.58
Long-Term Debt NA NA NA NA
Total Liabilities 1.17 1.64 1.03 0.58
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 103.34 103.05 83.06 82.28
Retained Earnings -122.94 -121.37 -119.08 -116.73
Treasury Stock NA NA NA NA
Total Stockholders' Equity 25.66 26.76 8.86 9.68
Total Liabilities and Stockholders' Equity 26.84 28.40 9.89 10.26

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -1.73 -1.32 -0.96 -0.69
Net Cash Provided by Investing Activities NA 0.00 NA NA
Net Cash Provided by Financing Activities 0.19 19.89 0.41 7.67

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.001.84--
12/20140.00-2.18-0.22
12/20150.00-0.66-0.06
12/20160.00-2.79-0.22
12/20170.00-7.05-0.47
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18237,62341.22




Report Date : 7/9/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.